Leo Pharma Eyes $800 Million Deal Push as IPO Plans Advance
Leo Pharma is actively seeking more acquisition targets, with as much as 5 billion kroner ($800 million) to spend on dealmaking as it positions itself for an initial public offering, according to its top management.
Original Source
Read the full article at Bloomberg →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.